E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia

European Journal of Surgical Oncology

Volumn 30, Issue 10, 2004, Pages 1084-1092

  Polkowski, Wojciech P ^a   Skomra, Danuta G ^a   Mielko, Jerzy ^a   Wallner, Grzegorz T ^a   Szumiło, Justyna ^a   Zinkiewicz, Krzysztof ^a   Korobowicz, Elzbieta M ^a   van Lanschot, J Jan B ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adenocarcinoma; Adhesion molecules; CD44v6; E cadherin; Gastro oesophageal junction; Radical resection

Indexed keywords

CD44V6 ANTIGEN; UVOMORULIN; CADHERIN; GLYCOPROTEIN; HERMES ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CARDIA CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GASTRECTOMY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURVIVAL RATE; ADENOCARCINOMA; CARDIA; CELL ADHESION; FORECASTING; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH TUMOR; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD44; CADHERINS; CARDIA; CELL ADHESION; FEMALE; FORECASTING; GASTRECTOMY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 13944272754     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.07.022     Document Type: Article

References (50)

1. W.J. Blot Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287-1289
2. K. Davessar J.C. Pezzullo N. Kessimian et al. Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications Hum Pathol 21 1990 325-332
3. P. Hermanek Prognostic factors in stomach cancer surgery Eur J Surg Oncol 12 1986 241-246
4. J.R. Siewert K. Bottcher H.J. Stein et al. Problem of proximal third gastric carcinoma World J Surg 19 1995 523-531
5. Y. Kajiyama M. Tsurumaru H. Udagawa et al. Prognostic factors in adenocarcinoma of the gastric cardia: Pathologic stage analysis and multivariate regression analysis J Clin Oncol 15 1997 2015-2021
6. A.H. Hölscher E. Bollschweiler J.R. Siewert Carcinoma of the gastric cardia Ann Chir Gynaecol 84 1995 185-192
7. J.R. Siewert H.J. Stein Classification of adenocarcinoma of the oesophagogastric junction Br J Surg 85 1998 1457-1459
8. J.R. Siewert H.J. Stein A. Sendler U. Fink Surgical resection for cancer of the cardia Semin Surg Oncol 17 1999 125-131
9. D.A. Sharpe K. Moghissi Resectional surgery in carcinoma of the oesophagus and cardia: What influences long-term survival? Eur J Cardiothorac Surg 10 1996 359-363
10. R.J. Jakl J. Miholic R. Koller et al. Prognostic factors in adenocarcinoma of the cardia Am J Surg 169 1995 316-319
11. S. Stipa A. Di Giorgio M. Ferri Surgical treatment of adenocarcinoma of the cardia Surgery 111 1992 386-393
12. K. Borch B. Jonsson E. Tarpila et al. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma Br J Surg 87 2000 618-626
13. B.P. Wijnhoven P.D. Siersema W.C. Hop et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group Br J Surg 86 1999 529-535
14. A.J. Graham R.J. Finley J.C. Clifton et al. Surgical management of adenocarcinoma of the cardia Am J Surg 175 1998 418-421
15. P. Hermanek C. Wittekind Residual tumour (R) classification and prognosis Semin Surg Oncol 10 1994 12-20
16. S. Mattioli M.P. Di Simone L. Ferruzzi et al. Surgical therapy for adenocarcinoma of the cardia: Modalities of recurrence and extension of resection Dis Esoph 14 2001 104-109
17. P.A. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma Acta Pathol Microbiol Scan 64 1965 31-49
18. L. Jonasson J. Hallgrimsson G. Olafsdottir Gastric carcinoma: correlation of diagnosis based on biopsies and resection specimens with reference to the Lauren classification APMIS 102 1994 711-715
19. G.R. Screaton M.V. Bell D.G. Jackson et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons Proc Natl Acad Sci USA 89 1992 12160-12164
20. C. Tolg M. Hofmann P. Herrlich H. Ponta Splicing choice from ten variant exons establishes CD44 variability Nucl Acids Res 21 1993 1225-1229
21. K.H. Heider J. Dammrich P. Skroch-Angel et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa Cancer Res 53 1993 4197-4203
22. J. Dammrich H.P. Vollmers K.H. Heider H.K. Muller-Hermelink Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading J Mol Med 73 1995 395-401
23. R.L. Hong W.J. Lee C.T. Shun et al. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas Oncology 52 1995 334-339
24. M. Takeichi Cadherins: A molecular family important in selective cell-cell adhesion Annu Rev Biochem 59 1990 237-252
25. M. Tanaka Y. Kitajima G. Edakuni et al. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer Br J Surg 89 2002 236-244
26. Y.E. Joo J.S. Rew H.S. Kim et al. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers Digestion 64 2001 111-119
27. Japanese Gastric Cancer Association The new Japanese classification of gastric carcinoma, 2nd English edition Gastric Cancer 1 1998 1-15
28. L.H. Sobin I.D. Fleming TNM Classification of Malignant Tumours, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 80 1997 1803-1804
29. P. Hermanek A. Altendorf-Hofmann U. Mansmann et al. Improvements in staging of gastric carcinoma from using the new edition of TNM classification Eur J Surg Oncol 24 1998 536-541
30. F.P. Gall P. Hermanek New aspects in the surgical treatment of gastric carcinoma - a comparative study of 1636 patients operated on between 1969 and 1982 Eur J Surg Oncol 11 1985 219-225
31. J.A. Jankowski P.M. Newham O. Kandemir et al. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: A putative biomarker Int J Oncol 4 1994 441-448
32. J. Mirecka D. Marx A. Schauer Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer Anticancer Res 15 1995 1459-1465
33. J.W. Mulder P.M. Kruyt M. Sewnath et al. Difference in expression of CD44 splice variants between proximal and distal adenocarcinoma of the large bowel Br J Surg 82 1995 1468-1470
34. J.R. Siewert M. Feith M. Werner H.J. Stein Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients Ann Surg 232 2000 353-361
35. S.P. Monig W. Schroder K.T. Beckurts A.H. Holscher Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction Hepatogastroenterology 48 2001 1231-1237
36. Y. Kodera Y. Yamamura Y. Shimizu et al. Adenocarcinoma of the gastroesophageal junction in Japan: Relevance of Siewert's classification applied to 177 cases resected at a single institution J Am Coll Surg 189 1999 594-601
37. P. Hermanek Surgical pathology - the TNM system Langebecks Arch Chir 358 1982 57-63
38. D.N. Papachristou N. Agnanti H. D'Agostino J.G. Fortner Histologically positive esophageal margin in the surgical treatment of gastric cancer Am J Surg 139 1980 711-713
39. J. Wayman S.M. Dresner S.A. Raimes S.M. Griffin Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia Br J Surg 86 1999 536-540
40. C. Mariette B. Castel J.M. Balon I. Van Seuningen J.P. Triboulet Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction Eur J Surg Oncol 29 2003 588-593
41. C. Mariette B. Castel H. Toursel S. Fabre J.M. Balon J.P. Triboulet Surgical management of and long-term survival after adenocarcinoma of the cardia Br J Surg 89 2002 1156-1163
42. A.G. Casson S.J. Darnton S. Subramanian L. Hiller What is the optimal distal resection margin for esophageal carcinoma? Ann Thorac Surg 69 2000 205-209
43. B. Husemann Cardia carcinoma considered as a distinct clinical entity Br J Surg 76 1989 136-139
44. W. Müller A. Schneiders K.H. Heider Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer J Pathol 183 1997 222-227
45. K. Kurozumi T. Nishida K. Nakao et al. Expression of CD44 variant 6 and lymphatic invasion: Importance to lymph node metastasis in gastric cancer World J Surg 22 1998 853-857
46. G. Tamura J. Yin S. Wang et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas J Natl Cancer Inst 92 2000 569-573
47. G. Tamura K. Sato S. Akiyama et al. Molecular characterization of undifferentiated-type gastric carcinoma Lab Invest 81 2001 593-598
48. Y. Ninomiya A. Yanagisawa Y. Kato H. Tomimatsu Unrecognizable intramucosal spread of diffuse-type mucosal gastric carcinomas of less than 20 mm in size Endoscopy 32 2000 604-608
49. J. Cai M. Ikeguchi S. Tsujitani et al. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer Gastric Cancer 4 2001 66-74
50. Y. Yonemura Y. Endou K. Kimura et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer Clin Cancer Res 6 2000 4234-4242